TY  - GEN
AU  - Perez,Cesar A
AU  - Santos,Edgardo S
AU  - Arango,Belisario A
AU  - Raez,Luis E
AU  - Cohen,Ezra E W
TI  - Novel molecular targeted therapies for refractory thyroid cancer
SN  - 1097-0347
PY  - 2012///0813
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Anilides
KW  - Antineoplastic Agents
KW  - Axitinib
KW  - Benzamides
KW  - Benzenesulfonates
KW  - Benzoquinones
KW  - Bibenzyls
KW  - Boronic Acids
KW  - Bortezomib
KW  - Depsipeptides
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Gefitinib
KW  - HSP90 Heat-Shock Proteins
KW  - Histone Deacetylase Inhibitors
KW  - Humans
KW  - Hydroxamic Acids
KW  - Imatinib Mesylate
KW  - Imidazoles
KW  - Indazoles
KW  - Indoles
KW  - Lactams, Macrocyclic
KW  - Lenalidomide
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Oligonucleotides
KW  - Phenylurea Compounds
KW  - Piperazines
KW  - Piperidines
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - Proto-Oncogene Proteins c-kit
KW  - Pyrazines
KW  - Pyridines
KW  - Pyrimidines
KW  - Pyrroles
KW  - Quinazolines
KW  - Quinolines
KW  - Receptor Protein-Tyrosine Kinases
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Sorafenib
KW  - Sulfonamides
KW  - Sunitinib
KW  - Thalidomide
KW  - Thyroid Neoplasms
KW  - drug therapy
KW  - Valproic Acid
KW  - Vorinostat
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1002/hed.21755
ER  -